Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients

Cancer immunotherapies have induced long-lasting responses in cancer patients including those with melanoma and head and neck squamous cell carcinoma (HNSCC). However, the majority of treated patients does not achieve clinical benefit from immunotherapy because of systemic tumor-induced immunosuppre...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Wigcheren, Glenn F., De Haas, Nienke, Mulder, Tom A., Horrevorts, Sophie K., Bloemendal, Martine, Hins-Debree, Simone, Mao, Yumeng, Kiessling, Rolf, van Herpen, Carla M.L., Flórez-Grau, Georgina, Hato, Stanleyson V., De Vries, I. Jolanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237969/
https://www.ncbi.nlm.nih.gov/pubmed/34239773
http://dx.doi.org/10.1080/2162402X.2021.1935557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237969/
https://www.ncbi.nlm.nih.gov/pubmed/34239773
http://dx.doi.org/10.1080/2162402X.2021.1935557

Ejemplares similares